secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001453687-24-000072
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian regains Nasdaq minimum bid price compliance; delisting risk removed
-----------------------------------------------------------------------------

- Received deficiency notice Jan 17, 2024 for bid price below $1.00 for 30 consecutive days.
- Compliance period granted until July 15, 2024 to cure the deficiency.
- On April 19, 2024, Nasdaq confirmed bid price ≥ $1.00 for 10 consecutive days from April 5-18.
- Nasdaq considers the matter closed; company remains listed on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000072/0001453687-24-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000072/rnac-20240419.htm
  HTML page:      https://secwatch.observer/filing/0001453687-24-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer